Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index; none of the 55 sources its claims cite is checked for support yet.

Minocycline-loaded PLGA electrospun membrane prevents alveolar bone loss in experimental peridontitis

Open access

Abstract

Minocycline (MINO) is a tetracycline antibiotic effective against most of the bacteria microorganisms related to periodontal disease. Additionally, MINO promotes bone in vitro and in vivo. The objective of the present study was to establish the protocol for the preparation of MINO-loaded poly (lactic-co-glycolic acid) (MINO-PLGA) electrospun membranes and to evaluate their effect on osteogenesis in vitro and in a rat model of periodontitis. The characterization of MINO-PLGA electrospun membranes was assessed by scanning electron microscopy, laser scanning confocal microscopy, and contact angle measurement. The drug release study showed a sustained diffusion of MINO from electrospun membranes over a period of 40 d. The MINO-PLGA membranes containing 2% of the drug exhibited better support of osteoblast proliferation and adhesion and was subsequently used in vivo in an experimental periodontitis model. Its therapeutic potential was evaluated by the measurement of alveolar bone loss (ABL), bone volume analysis, histological analysis, and immunohistochemistry. MINO-PLGA membrane increased alveolar crest height in the periodontitis model, inhibited the expression of the ligand of the receptor activator for nuclear factor-κB (RANKL), and promoted the expression of its inhibitor, osteoprotegerin. The study demonstrated that MINO-PLGA electrospun membranes may be applied to stimulate bone regeneration in periodontitis.

Overview

CoChat Summary

TL;DR

Minocycline-loaded PLGA electrospun membranes released MINO over 40 days and, especially at 2% MINO, supported osteoblast attachment and proliferation in vitro. In a ligature-induced rat periodontitis model, 2% MINO-PLGA increased alveolar bone parameters, reduced alveolar bone loss, decreased RANKL, and increased OPG compared with ligation/PLGA controls.

Key findings

  • MINO-PLGA fibers were ribbon-shaped with average diameters of 1661, 1618, 1579, and 1569 nm for 0%, 1%, 2%, and 3% MINO, respectively (p > .05); contact angles decreased significantly with MINO loading (86.970° ± 3.698°, 74.354° ± 6.917°, 73.686° ± 9.642°, 68.684° ± 12.580°; p < .05).
  • Release showed an initial burst on day 1 (21.11%, 23.17%, and 28.06% for 1%, 2%, and 3% MINO-PLGA) and sustained release over 40 d (76.33%, 81.26%, and 87.42%, respectively); the Ritger–Peppas model fit best (R² > 0.990), and residual membrane weight was approximately 52% at 60 d.
  • From day 3, osteoblast proliferation was significantly higher on MINO-PLGA membranes, particularly 2% MINO-PLGA, compared with PLGA (p < .05); SEM showed cells attached via filopodia.
  • In vivo, ABL at 3 weeks was 1.02 ± 0.084 mm (MINO-PLGA), 1.06 ± 0.076 mm (Periocline®), 1.23 ± 0.049 mm (ligation), and 1.20 ± 0.046 mm (PLGA); at 6 weeks it was 0.73 ± 0.055 mm, 0.84 ± 0.111 mm, 1.05 ± 0.097 mm, and 1.03 ± 0.114 mm, respectively. MINO-PLGA and Periocline® prevented ligature-induced BV/TV decreases versus ligation and PLGA (p < .05), and IHC showed decreased RANKL and increased OPG.

Methods

  • PLGA (LA:GA = 50:50, MW = 70,000) was dissolved in chloroform; MINO was added at 1, 2, or 3 wt%, and membranes were electrospun at 15 kV, 18 cm distance, and 3 mL/h. Characterization included SEM, FTIR, laser scanning confocal microscopy, and contact angle measurement.
  • In vitro, MINO release was measured in PBS at 37 °C by absorbance at 375 nm over 40 d; degradation was measured by weight loss. Osteoblasts from newborn Sprague–Dawley rat cranial bones were used for CCK-8 proliferation and SEM attachment assays.
  • In vivo, female Sprague–Dawley rats (7 weeks old) were randomized to five groups (n = 5 each): control, ligation, ligation + PLGA, ligation + 2% MINO-PLGA, and ligation + Periocline®. After 4 weeks of ligature-induced periodontitis, treatments were applied, and micro-CT, H&E histology, and immunohistochemistry for OPG/RANKL were assessed at 3 and 6 weeks; one-way ANOVA and SNK-q tests were used with p < .05.

Limitations

  • Paper-stated: co-electrospinning MINO with PLGA could not completely prevent the initial burst release, and the authors state that a better drug-loading method will be explored in future research to further reduce burst release.
  • Evident from the text: in vivo testing used only the 2% MINO-PLGA formulation, so no in vivo dose–response across 1%, 2%, and 3% MINO is established.
  • Evident from the text: antimicrobial efficacy was not directly assessed despite the antibiotic rationale, and several in vivo/assay groups used small sample sizes (n = 5 in vivo; n = 3 for some in vitro and IHC analyses).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/10717544.2019.1709921

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. (A) SEM images of fibers and cells grown on the membranes (SEM scale bar = 60 µm) of PLGA (a, e), 1% MINO-PLGA (b. f), 2% MINO-PLGA (c, g), and 3% MINO-PLGA (d, h), (B) laser scanning confocal microscopy images of 1% MINO-PLGA (a, d, g), 2% MINO-PLGA (b, e, h), 3% MINO-PLGA (c, f, i). Fluorescent picture, bright field picture and composite picture from left to right respectively (scale bar = 50µm).
Figure 1. (A) SEM images of fibers and cells grown on the membranes (SEM scale bar = 60 µm) of PLGA (a, e), 1% MINO-PLGA (b. f), 2% MINO-PLGA (c, g), and 3% MINO-PLGA (d, h), (B) laser scanning confocal microscopy images of 1% MINO-PLGA (a, d, g), 2% MINO-PLGA (b, e, h), 3% MINO-PLGA (c, f, i). Fluorescent picture, bright field picture and composite picture from left to right respectively (scale bar = 50µm).CC BY · PubMed Central
Figure 2. (A) MINO release properties from the 1%, 2%, and 3% MINO-PLGA membranes, (B) weight loss of 0%, 1%, 2%, and 3% MINO-PLGA membranes. The data represented the mean ± standard deviation (n = 7 for release and n = 3 for degradation), (C) CCK-8 assays of cells cultured on 0%, 1%, 2%, and 3% MINO-PLGA membranes. The data represented the mean ± SD, n = 3, *p < .05, (D) FTIR spectra of MINO, PLGA and 2% MINO-PLGA electrospun membranes.
Figure 2. (A) MINO release properties from the 1%, 2%, and 3% MINO-PLGA membranes, (B) weight loss of 0%, 1%, 2%, and 3% MINO-PLGA membranes. The data represented the mean ± standard deviation (n = 7 for release and n = 3 for degradation), (C) CCK-8 assays of cells cultured on 0%, 1%, 2%, and 3% MINO-PLGA membranes. The data represented the mean ± SD, n = 3, *p < .05, (D) FTIR spectra of MINO, PLGA and 2% MINO-PLGA electrospun membranes.CC BY · PubMed Central
Figure 3. Reconstructed three-dimensional micro-CT images (buccal and palatal view) of the maxilla first molars alveolar bone level in control (C), ligation, ligation + PLGA, ligation + MINO-PLGA and ligation + Periocline® group at 3 weeks (A) and 6 weeks (B).
Figure 3. Reconstructed three-dimensional micro-CT images (buccal and palatal view) of the maxilla first molars alveolar bone level in control (C), ligation, ligation + PLGA, ligation + MINO-PLGA and ligation + Periocline® group at 3 weeks (A) and 6 weeks (B).CC BY · PubMed Central
Figure 4. (A) The degree of alveolar bone loss was evaluated by measuring the CEJ-ABC distance at the distal and mesial root of the first molar from the reconstructed micro-CT images, (B) analysis of micro-CT volumetric parameters: bone volume/tissue volume (BV/TV). The data represented the mean ± SD, n = 5, *p < .05.
Figure 4. (A) The degree of alveolar bone loss was evaluated by measuring the CEJ-ABC distance at the distal and mesial root of the first molar from the reconstructed micro-CT images, (B) analysis of micro-CT volumetric parameters: bone volume/tissue volume (BV/TV). The data represented the mean ± SD, n = 5, *p < .05.CC BY · PubMed Central
Figure 5. Histological observation (H&E stain) of maxillary periodontal tissue after 3 and 6 weeks (40 × magnification, bar = 500 µm).
Figure 5. Histological observation (H&E stain) of maxillary periodontal tissue after 3 and 6 weeks (40 × magnification, bar = 500 µm).CC BY · PubMed Central
Figure 6. IHC staining and the corresponding quantitative analysis of OPG and RANKL after 3 and 6 weeks (400 × magnification, bar = 50 µm). The results represent the mean ± SD, n = 3, *p < .05.
Figure 6. IHC staining and the corresponding quantitative analysis of OPG and RANKL after 3 and 6 weeks (400 × magnification, bar = 50 µm). The results represent the mean ± SD, n = 3, *p < .05.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 35 Not checked · 57 Own results and interpretations

44 more claims

Create a free account to see all 92 claims and to verify the 41 references still open.

See all claims — free account
  • Probably not a substantial claim. 23
  • It may state two separate claims as one. 31

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 5

Citations

Cites

Show all 43 references

Cited by

See all 51

Metadata

Authors
Ma, Y., Song, J., Almassri, H. N. S., Zhang, D., Zhang, T., Cheng, Y., & Wu, X.
Affiliations
  • Stomatological Hospital of Chongqing Medical University (CN)
  • Stomatological Hospital of Chongqing Medical University, Yubei District, Chongqing, China
Corresponding author
Wu, Xiaohong
Venue
Drug Delivery
Published
2020-01
Volume
27
Issue
1
Pages
151-160
ISSN
  • 1071-7544 (ISSN-L)
  • 1521-0464
OpenAlex
W3000048516
Cited by
51
References
43
Citations by year
2026: 2 · 2025: 7 · 2024: 13 · 2023: 8 · 2022: 5 · 2021: 10 · 2020: 6
FWCI
1.76
Type
journal article
Language
en
Open access
Locations
  • Drug Delivery (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81970914, 81570981)
  • Chongqing Yuzhong Science and Technology Project (20170117)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
  • Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
minocycline, PLGA, electrospun membranes, periodontitis, alveolar bone loss, bone formation, osteoblast proliferation, sustained drug release, RANKL, osteoprotegerin, bone regeneration, tetracycline antibiotics
MeSH terms
Animals, Bone Regeneration, Cells, Cultured, Minocycline, Osteoblasts, Osteogenesis, Polyglycolic Acid, Alveolar Bone Loss, Rats, Tissue Scaffolds, Drug Liberation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Minocycline-loaded PLGA electrospun membrane prevents alveolar bone loss in experimental peridontitis. https://app.cochat.ai/papers/10.1080/10717544.2019.1709921
The paper
Ma, Y., Song, J., Almassri, H. N. S., Zhang, D., Zhang, T., Cheng, Y., & Wu, X. (2020). Minocycline-loaded PLGA electrospun membrane prevents alveolar bone loss in experimental peridontitis. Drug Delivery. https://doi.org/10.1080/10717544.2019.1709921

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.